Delivery Order SPE2DR25D1017-SPE2DR26F9BGL
- Not listed
- The Defense Logistics Agency awarded a $2,907.40 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,635.36 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on November 17, 2025, with completion targeted for November 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing contract vehicle. The pharmaceutical product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,458.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger contract vehicle and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Trulicity is a prescription diabetes medication commonly used within military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,628.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 4, 2025. This non-set-aside, firm fixed-price delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. Trulicity is a brand-name diabetes medication commonly used within federal healthcare systems, including military and...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,744.44 for Trulicity 3 mg/0.5 mL pens on December 11, 2025, with an ultimate completion date of December 12, 2025. This firm fixed price, non-set-aside contract was awarded competitively and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $11,729.40 with a firm fixed-price structure. This delivery order represents a non-set-aside competitive award and is part of AmerisourceBergen's broader relationship with DLA as a critical pharmaceutical distributor. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 13, 2025, valued at $1,201.20 for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 14, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,153.54. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 10, 2025, and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems, representing the...
- The Defense Logistics Agency (DLA) awarded a $5,734.19 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication, representing one of many pharmaceutical products AmerisourceBergen...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BGLDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,744.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on December 11, 2025, with an ultimate completion date of December 12, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems, reflecting the DLA's ongoing procurement needs for pharmaceutical supplies across the Department of Defense. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen's status as a major pharmaceutical distributor and its demonstrated capability to win competitive federal awards positions it as a critical vendor for military medical supply chain operations, serving entities including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/10/25 |